申请人:GENENTECH, INC.
公开号:US20190031607A1
公开(公告)日:2019-01-31
The invention provides compounds having the general Formula (I);
and pharmaceutically acceptable salts thereof; wherein the variables R
A
, R
AA
, subscript n, subscript q, ring A, X
2
, L, subscript m, X
1
, R
1
, R
2
, R
3
, R
4
, R
5
, D and E have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.